EU Cancer Mission & Japan’s Cancer Centre team up at Osaka Expo
EU Cancer Mission and Japan’s National Cancer Centre join forces at Osaka Expo to tackle cancer together
Osaka Expo 2025
On 16 July 2025, the EU Cancer Mission and Japan’s National Cancer Centre hosted a collaborative event at the EU Pavilion during Expo 2025 Osaka. The session, titled “Fighting Cancer: How the EU Cancer Mission and Japan’s National Cancer Centre Address the Challenge,” spotlighted adolescents and young adults (AYA), shared survivor stories, and emphasized international cooperation in research, trial design, and patient‑centered solutions.
Youth voices lead the way
At the heart of the discussion was a shared priority: improving quality of life during and after cancer – especially for adolescents and young adults (AYAs). Survivors from both Europe and Japan shared personal stories that revealed striking similarities in their experiences. These exchanges highlighted the importance of building a global AYA community that offers peer support, fosters learning and strengthens advocacy.
A unified path forward
As the session closed, a shared belief emerged among participants from both continents: international cooperation is essential to advance cancer research and care. By breaking down barriers, pooling knowledge and elevating patient voices, groundwork for a new era of collaborative cancer research is being laying down.
#EuCanScreen #CancerScreening #HealthCare #CancerPrevention #AYA #OsakaExpo2025
🔗 Please don’t forget to Subscribe to EuCanScreen Newsletter! 💪
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
